Friend of Monsanto, Pfizer Tries to Dodge $35 Billion Tax Bill
After price-gouging sick Americans for its pharmaceutical drugs, Pfizer plans to slip under the IRS’s radar and dodge an estimated $35 billion tax bill by merging with a foreign company (a $160 billion buyout).
